Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species

Area of Science:

• Oncology
• Cell Biology
• Genetics

Background:

• Ras signaling pathway activation is common in human cancers but insufficient for tumorigenesis.
• Autophagy, a cellular degradation process, has been implicated in cancer, with roles that can be tumor-suppressive or tumor-promoting.

Purpose of the Study:

• To investigate the role of autophagy in cooperating with oncogenic Ras signaling in tumor development.
• To explore the therapeutic potential of targeting the autophagy pathway in Ras-driven cancers.

Main Methods:

• Utilized Drosophila melanogaster as a model organism for genetic screening.
• Conducted bioinformatic analysis of human tumor datasets.
• Investigated the effects of blocking autophagy on Ras-driven epithelial overgrowth, reactive oxygen species levels, and stress response pathways.

Main Results:

• Identified autophagy genes as tumor suppressors cooperating with oncogenic Ras (RasV12) in Drosophila.
• Found correlation between core autophagy genes and poor prognosis in human pancreatic cancer with KRAS mutations.
• Demonstrated that blocking autophagy enhances RasV12-driven tissue overgrowth via reactive oxygen species accumulation and Jun kinase activation.
• Observed non-cell-autonomous effects of blocked autophagy in RasV12 clones, inducing autophagy, proliferation, and caspase activation in neighboring wild-type cells.

Conclusions:

• Autophagy plays a tumor-suppressive role in Ras-driven tumorigenesis.
• Interplay between Ras signaling and autophagy is critical in cancer development.
• Targeting autophagy presents a potential therapeutic strategy for Ras-driven cancers.